Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin | Patent Number 08158644

US 08158644 B2
Application Number13041347
Publication NumberUS 20110152516 A1
Pendency1 year, 1 month, 15 days
Filled DateMar 4, 2011
Priority DateNov 4, 2004
Publication DateJun 23, 2011
Expiration DateNov 4, 2024
Inventor/ApplicantsVincenzo Cannata
Manuela Campana
Donatella Confortini
Goffredo Rosini
Paolo Righi
Giuseppe Claudio Viscomi
Dario Braga
ExaminesKIFLE, BRUCK
Art Unit1622
Technology Center1600
Assignments
Alfa Wassermann S.p.a.
Current
Alfa Wassermann S.p.a.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.